Treatment for Kanakadi (Urticaria) by using Gandhaga rasayanam and Arugan thylam

A Clinical evaluation of Siddha formulation Gandhaga rasayanam(Internal medicine) and Arugan thylam(External medicine) for Kaanakadi(Urticaria) - nil

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/11/047671

Enrollment

Registered

2022-11-25

Start date

Unknown

Completion date

Unknown

Last updated

2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L509- Urticaria, unspecified

Interventions

Intervention1: Gandhaga rasaayanam (internal medicine) and Arugan thylam (external medicine): Gandhaga rasaayanam 6g bd with Milk Arugan thylam 20ml for external applications

Eligibility

Inclusion criteria

Inclusion criteria: Patients with clinical symptoms of Itching Redness Pale pink oedematous wheal Wheals surrounded by flare Inflamation Erythematous macules (any 2 symptoms especially itchy,wheal) Recurrent episodes of urticaria

Exclusion criteria

Exclusion criteria: Any serious systemic illness Psoriasis Eczema Tinea infection Pregnancy Lactation Psychological factor Adverse reaction of any drug

Design outcomes

Primary

Measure	Time frame
Effect of Gandhaga rasayanam(internal) and arugan thylam(external) in the management of urticaria will be assessed by based on urticaria activity score(UAS) and IgE in study subjects before and after the treatment.Timepoint: 48 Days	—

Secondary

Measure	Time frame
NILTimepoint: NIL	—

Countries

India

Contacts

Public ContactDr S MANJU

National Institute of Siddha

drmadhavanji@gmail.com9965561656

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026